StemCells Gains 5% on Neural Stem Cell Trial in Spinal Cord Injury

Posted: Published on September 24th, 2011

This post was added by Dr. Richardson



Shares of StemCells (STEM) are up 5.85% after the company announced that it will initiate the Phase I/II clinical trial of its proprietary HuCNS-SC human neural stem cells in chronic spinal cord injury. The trial is now open for enrollment, and will accept patients with both complete and incomplete degrees of paralysis who are three to twelve months post-injury. It is being conducted in Switzerland at the Balgrist University Hospital, University of Zurich

Continue reading here:
StemCells Gains 5% on Neural Stem Cell Trial in Spinal Cord Injury

Related Posts
This entry was posted in Stem Cell Human Trials. Bookmark the permalink.

Comments are closed.